Screening of natural products for antimicrobial agents L. SilverK. Bostian OriginalPaper Pages: 455 - 461
Remarks on the screening of antibiotics for antibacterial activity O. ZakH. MettT. O'Reilly OriginalPaper Pages: 462 - 465
Animal models as predictors of the safety and efficacy of antibiotics O. ZakT. O'Reilly OriginalPaper Pages: 472 - 478
Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models A. DalhoffU. Ullmann OriginalPaper Pages: 479 - 487
Basic requirements for the toxicity testing of antimicrobial agents R. BassT. Lehnert OriginalPaper Pages: 488 - 491
European standards for antibiotic susceptibility testing: Towards a theoretical consensus F. Baquero OriginalPaper Pages: 492 - 495
Prospects for standardisation of methods and guidelines for disc susceptibility testing J. D. Williams OriginalPaper Pages: 496 - 501
Requirements for the documentation of pharmacokinetic properties of antimicrobial agents T. Bergan OriginalPaper Pages: 506 - 509
Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage C. Carbon OriginalPaper Pages: 510 - 516
Evaluation of safety and tolerance in clinical trials with antimicrobial agents H. LodeR. Stahlmann OriginalPaper Pages: 530 - 533
Evaluation of methods for recording adverse drug reactions in clinical trials B. S. Nilsson OriginalPaper Pages: 534 - 536
Regulatory requirements for clinical evaluation of antimicrobial agents W. Christ OriginalPaper Pages: 537 - 541
The clinical evaluation of antibacterial drugs: Guidelines of the british society for antimicrobial chemotherapy R. G. Finch OriginalPaper Pages: 542 - 547
Guidelines of the world health organization for clinical trials with antimicrobial agents I. Lunde OriginalPaper Pages: 548 - 551
The implications for europe of revised FDA guidelines for clinical trials with anti-infective agents D. N. GilbertT. R. BeamC. M. Kunin OriginalPaper Pages: 552 - 558
